[Skip to Content]
[Skip to Content Landing]
Article
September 1952

OCULAR AND SUBCUTANEOUS INFLAMMATORY RESPONSES TO TRANSPLANTATION OF HETEROLOGOUS TUMORS

Author Affiliations

ROCHESTER, N. Y.
From the Divisions of Ophthalmology and Cancer Research, Department of Surgery, the University of Rochester School of Medicine and Dentistry.

AMA Arch Ophthalmol. 1952;48(3):298-306. doi:10.1001/archopht.1952.00920010306004
Abstract

THIS INVESTIGATION was undertaken to study the differences between the ocular and the subcutaneous inflammatory responses following heterologous tumor transplantation, and to determine whether such differences could account for the superiority of the ocular route as a transplantation site.

That such differences do occur appears to have been taken as self-evident in many of the published reports dealing with the ocular transplantation of tumors. For example, Smirnova1 assumed that the "agents of defense" could not act in the: anterior chamber but presented no evidence to support this hypothesis. Greene2 stated that the eye differs from other transplantation sites in the rapidity and intensity of foreign-body reactions. Greene, furthermore, concluded that these differences account for the success of transplants in the ocular area. On the other hand, Morris and associates3 described destruction of tumor heterotransplants in the eye by lymphocytes, plasma cells, and, occasionally, foreign body giant cells.

First Page Preview View Large
First page PDF preview
First page PDF preview
×